Menu
1 min read · estimated
APPROVED USE
What FDA approved
With lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma.
LAMPGEN ANALYSIS
Why it matters
The three-drug regimen adds a CD19-directed antibody to rituximab and lenalidomide in recurrent disease.
What research teams should watch
Prepare a joint infusion and oral-drug calendar and document infection and cytopenia assessments across components.
PRIMARY RECORDS